You are on the new improved site. You can view the old site in view-only mode here until June 27, 2026

Filter Results

Select search scope: search across all journals or within the current journal

Search this journal

Enter search terms…

Advanced search

/

About

About Sage
About Sage Journals
Privacy Policy
Terms of Use
Contact Us
Help

Information for

Authors
Editors
Librarians
Researchers
Reviewers
Frequently asked questions

Copyright © 2026 by Sage Publications.京ICP备09090397号-11

Multiple Sclerosis Journal

Impact Factor: 5.0 / 5-Year Impact Factor: 5.2

Journal Homepage Submission guidelines

Restricted access

Letter

First published online 2017-10

Patient-to-patient transmission of natalizumab-associated PML?

, , and

Volume 23, Issue 11

https://doi.org/10.1177/1352458517701316

Abstract

Get full access to this article

View all access options for this article.

References

1.

Bacchetta

F

Mathias

A

Schluep

M

et al . Progressive multifocal leukoencephalopathy in two natalizumab-treated stepsisters: An intriguing coincidence. Mult Scler 2017; 23(2): 300–303.

2.

Havla

J

Berthele

A

Kumpfel

T

et al . Co-occurrence of two cases of progressive multifocal leukoencephalopathy in a natalizumab “infusion group.” Mult Scler 2013; 19(9): 1213–1215.

Browse journal

Current issue OnlineFirst All issues

Similar articles

Retricted access

Novel MRI metrics: Is targeting brain atrophy a practical treatment goal? Yes

Retricted access

Sex differences in the experience of pain in the UK Biobank cohort study

Retricted access

Data handling in clinical trials: an ongoing debate

Retricted access

Chemokines and chemokine receptors in the pathogenesis of multiple sclerosis